SCHEMBL405926

SCHEMBL405926

CC(=O)Nc1c(F)cc(C)cc1[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
GAA P10253 4/20 0.48
HPGD P15428 2/20 0.48
GPR35 Q9HC97 1/20 0.47
MAPT P10636 5/20 0.46
KDM4E B2RXH2 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
LMNA P02545 3/20 0.43
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 2/20 0.42
POLB P06746 2/20 0.42
GALR2 O43603 1/20 0.42
MITF O75030 1/20 0.42
HSP90AA1 P07900 1/20 0.42
XBP1 P17861 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28836799 0.89 GPR35 (0.55) ALDH1A1GAAHPGDGPR35MAPT
SCHEMBL3449671 0.86 MAPT (0.47) ALDH1A1GAAHPGDMAPTKDM4E
SCHEMBL3635385 0.84 ALDH1A1 (0.65) ALDH1A1GAAHPGDGPR35MAPT
SCHEMBL27883929 0.81 ALDH1A1 (0.48) ALDH1A1GAAHPGDGPR35MAPT
SCHEMBL12225198 0.81 ALDH1A1 (0.48) ALDH1A1GAAHPGDGPR35MAPT
SCHEMBL10285834 0.81 HRAS (0.48) ALDH1A1GAAHPGDMAPTKDM4E
SCHEMBL19737473 0.80 ALDH1A1 (0.49) ALDH1A1GAAHPGDGPR35MAPT
SCHEMBL30002654 0.80 MAPT (0.45) ALDH1A1GAAHPGDMAPTKDM4E
SCHEMBL10472926 0.80 MAPT (0.45) ALDH1A1GAAHPGDMAPTKDM4E
SCHEMBL8533944 0.79 ALDH1A1 (0.45) ALDH1A1GAAHPGDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 US disclosed
EP-4590674-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2025-07-30 EP disclosed
CN-102807568-A Thiadiazole derivative DPP-IV (dipeptidyl peptidase IV) inhibitor JIANGSU CHIA TAI TIANQING PHAR 2012-12-05 CN disclosed
US-20120065187-A1 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE ALCON RESEARCH, LTD (US) 2012-03-15 US disclosed
US-20110257137-A1 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE KALYPSYS, INC. (US) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 ALDH1A1 2719/4885GAA 3156/4885HPGD 520/4885
US-20120065187-A1 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE HRH4, HRH3, HRH2 ALDH1A1 1909/4885GAA 3072/4885HPGD 252/4885
US-20110257137-A1 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE HRH4, HRH3, HRH2 ALDH1A1 1909/4885GAA 3072/4885HPGD 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.